Study to Evaluate the Effect of SCY-078 on the PK of Dabigatran in Healthy Subjects

NCT04092725 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: DAB
DRUG: SCY-078 plus DAB

Sponsor

Scynexis, Inc.

Collaborators

[object Object]